Deutsche Bank sets $31 target for Denali Therapeutics stock
Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...
SG Americas Securities LLC Acquires 6,195 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
SG Americas Securities LLC increased its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 128.8% in the 4th quarter, according to the company in its most recent filing ...
Alaska Dispatch News20d
Denali vs. McKinley: A brief history of the long debate over what to call North America’s highest mountain
At 20,310 feet tall, Denali is visible for hundreds of miles around. For thousands of years, it has been called not just Denali but a variety of names by Alaska Native people living around the ...
Forbes21d
Trump Renames Denali To Mount McKinley—Here’s What To Know
President Donald Trump signed an executive order Monday renaming Denali—the highest peak in North America—to Mount McKinley, the Alaska mountain’s name prior to 2015, a move he has suggested ...
Trump signs order seeking to rename Alaska’s Denali and the Gulf of Mexico
President Donald Trump said the Gulf of Mexico will be called the Gulf of America, while the Denali mountain peak will revert ...
ETF Daily News12d
Denali Therapeutics (NASDAQ:DNLI) Price Target Cut to $40.00 by Analysts at The Goldman Sachs Group
Denali Therapeutics (NASDAQ:DNLI – Free Report) had its target price trimmed by The Goldman Sachs Group from $45.00 to $40.00 in a research report sent to investors on Tuesday morning ...